(Press-News.org)
BGI Genomics recently joined a mission business to South America in April 2023. Given that this continent ranks fourth in area and fifth in population worldwide, the economic and healthcare enhancement potential of this continent is compelling.
Every South American country faces different healthcare challenges and priorities. Still, the promise of precision medicine is clear: It offers an opportunity to shift the delivery of care from a legacy one-size-fits-all approach to applying the right treatment for the right patient at the right time.
To help deliver on precision medicine's potential, BGI Genomics considers genetic testing to be pivotal to the medical screening, diagnosis and treatment of diseases. As a leading integrated solutions provider of precision medicine, the company looks forward to long-term cooperation with leading local partners to further enhance health outcomes.
At the China-Brazil Economic and Trade Cooperation Conference in the city of Sao Paulo, BGI Genomics and Brazlex Medical Genetics, a leader in medical testing in the country, signed a cooperation agreement on April 17, agreeing to long-term cooperation in clinical medical testing and introducing the company's products and services to the Brazilian market, such as prenatal screening and cancer tumor screening.
Subsequently, on April 17, the company signed a substantial order with Biogenar, a leading precision medicine service provider in Argentina, which plans to purchase a large-scale high-throughput sequencing platform system and related automation equipment for local scientific research and enhance clinical services.
BGI Genomics has also reached a cooperation agreement with diagnostic service carrier Biocodices will provide a complete set of non-invasive prenatal genetic testing equipment and solutions to this Buenos Aires-based company. With this partnership, testing is done locally instead of sending samples to overseas laboratories, thus reducing the cost for local pregnant women and helping Argentina improve maternal health services.
The Precision Oncology Center of Universidad Mayor, a leading Chilean university, also obtained two cutting-edge sequencers and other equipment from BGI Genomics. This partnership will help launch Chile's most extensive cancer genomics laboratory. The signing ceremony of this agreement was held on April 18, attended by the Vice Chancellor of Research, Nicole Trefault, and the general manager for Latin America, BGI Genomics, Liang Wu.
Dr. Patricio Manque, Scientific Director of the Center, highlights that this is a new step in expanding its capacities. "The Precision Oncology Center puts medicine at the service of the people in an unprecedented effort to move towards democratizing access to frontier medical treatments in the area of cancer, the leading cause of death in our country. We now can rely on the most important sequencing laboratory in Chile with equipment that allows analysis to be carried out in greater depth, in less time, and at a lower cost."
Liang Wu notes that the company seeks to benefit the local population by elevating technological health standards, "Over the past few years, we have embarked on a series of collaborative projects in Latin America, yielding remarkable outcomes. Our collaborations encompass establishing laboratories, providing technical support, and implementing training programs."
About BGI Genomics
BGI Genomics, headquartered in Shenzhen, China, is the world's leading integrated solutions provider of precision medicine. Our services cover over 100 countries and regions, involving more than 2,300 medical institutions. In July 2017, as a subsidiary of BGI Group, BGI Genomics (300676.SZ) was officially listed on the Shenzhen Stock Exchange.
END
WASHINGTON—In a new Scientific Statement released today, the Endocrine Society identifies areas for future endocrine research to reduce health disparities in pediatric and sexual and gender minoritized populations.
This Scientific Statement expands the Society’s 2012 statement by focusing on endocrine disease disparities in the pediatric and sexual and gender minoritized populations. These include pediatric and adult lesbian, gay, bisexual, transgender, queer, intersex and asexual (LGBTQIA) people. The writing group focused on prevalent conditions such as growth disorders, puberty disorders, ...
PULLMAN, Wash. —Short science-backed messages about the health risks of using cannabis while pregnant could be an effective way to discourage the dangerous trend.
In a new study published in Psychology of Addictive Behaviors, researchers at Washington State University found that conveying simple, scientific facts about how THC can harm a fetus was associated with reduced intentions to use cannabis while pregnant. This held true for messaging that was written to a group of women, aged 18-40, in either a narrative, story-based format or a non-narrative, factual-based one.
Additionally, the researchers found that short and simple communications designed to increase media literacy, ...
WILMINGTON, Del. (May 16, 2023) – As part of the Foundation for the National Institutes of Health (FNIH) Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium (AMP® BGTC), Nemours Children’s Health has been chosen to conduct a first-of-its-kind gene therapy clinical trial for Morquio A syndrome.
Nemours Children’s will work collaboratively with the FNIH AMP® BGTC, a public-private partnership between the National Institutes of Health (NIH), U.S. Food and Drug Administration (FDA), biopharmaceutical and life science companies, and non-profit ...
EMBARGO: 16 May 2023 at 08:00 CEST
Paris, France. At EuroPCR 2023, the interventional community paid tribute to Emergency Medical Services throughout the world for their critical role in enabling timely care. International representatives of emergency medical services received the Andreas Grüntzig Ethica Award at the opening ceremony of this year’s Course, further spotlighting the importance of their work in the establishment of networks for the care of STEMI patients.
This year, EuroPCR 2023 celebrated 30 years of primary percutaneous coronary ...
Prof. dr. René Medema has an excellent scientific track record. He leads a prominent research group and has an extensive national and international network. He also has more than ten years of executive experience in a position with final responsibility as chairman of the board of the Antoni van Leeuwenhoek. Medema is very motivated to fulfill the administrative role in the Princess Máxima Center, he says. ‘It’s great to make a substantial contribution to further improving the prospects for ...
UPTON, NY—Hydrogen, the simplest element on Earth, is a clean fuel that could revolutionize the energy industry. Accessing hydrogen, however, is not a simple or clean process at all. Pure hydrogen is extremely rare in nature, and practical methods to produce it currently rely on fossil fuels. But if scientists find the right chemical catalyst, one that can split the hydrogen and oxygen in water molecules apart, pure hydrogen could be produced from renewable energy sources such as solar power.
Now, ...
“In the present study, we used multiple complementary approaches to evaluate the possible effects of zoledronic acid on cellular senescence.”
BUFFALO, NY- May 15, 2023 – A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 9, entitled, “In vitro and in vivo effects of zoledronic acid on senescence and senescence-associated secretory phenotype markers.”
Zoledronic acid has been found to reduce fracture ...
URBANA, Ill. — From self-driving tractors to weeding robots and AI-powered data collection, automated machinery is revolutionizing agricultural production. While these technological advancements can greatly improve productivity, they also raise new questions about safety measures and regulations. To address these issues, a recent study from the University of Illinois reviewed current academic literature on the safety of automated agricultural machines. Based on a review of more than 60 papers, the researchers identified three ...
1. Experts say it’s not yet time to take off masks in the health care setting
Abstract: https://www.acpjournals.org/doi/10.7326/M23-1190
URL goes live when the embargo lifts
A new commentary from infectious disease experts at George Washington University School of Medicine and the National Institutes of Health (NIH) says for patient safety, masking should continue in health care settings. This message conflicts with a recent commentary from authors from 8 U.S. institutions suggesting that the time for universal masking is over. The commentary is published in Annals of Internal Medicine.
Masking has been a controversial ...
New University of Colorado Boulder research shows the number of farms globally will shrink in half as the size of the average existing farms doubles by the end of the 21st century, posing significant risks to the world’s food systems.
Published today in the journal Nature Sustainability, the study is the first to track the number and size of farms year-over-year, from the 1960s and projecting through 2100.
The study shows that even rural, farm-dependent communities in Africa and Asia will experience a drop in the number of operating farms.
“We see a turning point from widespread farm creation to widespread consolidation on a global level, and that's ...
